Letter: Electroconvulsive therapy in patients with parkinsonism.
D000547:Amantadine / Q000009:adverse effects* / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D003863:Depression / Q000139:chemically induced* / Q000628:therapy; D004155:Diphenhydramine / Q000506:poisoning / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008723:Methohexital / Q000627:therapeutic use; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D013390:Succinylcholine / Q000627:therapeutic use; D013405:Suicide
D007980:Levodopa; D001285:Atropine; D004155:Diphenhydramine; D000547:Amantadine; D008723:Methohexital; D013390:Succinylcholine